No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ICUI240719P95000
- 11.40
- 0.000.00%
15min DelayTrading Dec 19 11:14 ET
0.00High0.00Low
0.00Open11.40Pre Close0 Volume0 Open Interest95.00Strike Price0.00Turnover225.18%IV28.23%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry11.40Extrinsic Value100Contract SizeAmericanOptions Type-0.2522Delta0.0056Gamma10.22Leverage Ratio-0.5263Theta-0.0181Rho-2.58Eff Leverage0.0815Vega
Intraday
- 5D
- Daily
News
United States Home Infusion Therapy Market Analysis 2024: A $19+ Billion Industry by 2032 Featuring Baxter, BD and Co, Eli Lilly & Co, Fresenius, ICU Medical, Option Care Health, & Terumo - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "United States Home Infusion Therapy Market Report by Application, Product, States and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offeri
ICU Medical Insiders Sell US$9.7m Of Stock, Possibly Signalling Caution
Many ICU Medical, Inc. (NASDAQ:ICUI) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more
ICU Medical, Inc.'s (NASDAQ:ICUI) Intrinsic Value Is Potentially 34% Above Its Share Price
Needham Starts ICU Medical at Hold, Cites Limited Revenue Growth
Express News | ICU Medical Inc : Needham Initiates Coverage With Hold Rating
Needham Initiates ICU Medical(ICUI.US) With Hold Rating
Needham analyst Michael Matson initiates coverage on $ICU Medical(ICUI.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 41.2% and a total average return of -7.8% o
Comments
The recent insider sale of ICU Medical shares at around the current price of US$104 raises caution. The absence of insider buying over the past year and the recent sale does not inspire confidence in the company despite high insider ownership.
Chief Operating Officer Christian Voigtlander Sold A Bunch Of Shares In ICU Medical 1
Analysts hold steady on ICU Medical's revenue estimates and price target despite larger than expected losses. However, they anticipate a significant slowdown in the company's revenue growth, underperforming the wider industry.
The company's lower P/S ratio could be indicative of investor anticipation of less-impressive revenue performance moving forward. Some shareholders appear uneasy due to the company's weaker future prospect in terms of revenue growth.
1
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
21
Read more